CD4 and relapsing-remitting multiple sclerosis: However, in remitting phase, the expression levels of miR-21 were decreased in CD4 + T cells of RRMS patients, which could be used as a diagnostic biomarker to help distinguish relapsing and remitting phases in RRMS patients.